Pedrol E - Search Results

1

Lack of muscle toxicity with didanosine (ddI). Clinical and experimental studies.

Pedrol E, Masanés F, Fernández-Solá J, Cofan M, Casademont J, Grau JM, Urbano-Márquez A. Pedrol E, et al. J Neurol Sci. 1996 Jun;138(1-2):42-8. doi: 10.1016/0022-510x(96)00009-3. J Neurol Sci. 1996. PMID: 8791237

2

Chronic fatigue syndrome: studies on skeletal muscle.

Grau JM, Casademont J, Pedrol E, Fernández-Solà J, Cardellach F, Barros N, Urbano-Márquez A. Grau JM, et al. Among authors: pedrol e. Clin Neuropathol. 1992 Nov-Dec;11(6):329-32. Clin Neuropathol. 1992. PMID: 1473316

3

[A comparative study of the clinical and histological characteristics between classic nemaline myopathy and that associated with the human immunodeficiency virus].

Miró O, Masanés F, Pedrol E, García-Carrasco M, Mallolas J, Casademont J, Grau JM. Miró O, et al. Among authors: pedrol e. Med Clin (Barc). 1995 Oct 21;105(13):500-3. Med Clin (Barc). 1995. PMID: 7494440 Spanish.

4

Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.

Grau JM, Masanés F, Pedrol E, Casademont J, Fernández-Solá J, Urbano-Márquez A. Grau JM, et al. Among authors: pedrol e. Ann Neurol. 1993 Aug;34(2):206-11. doi: 10.1002/ana.410340217. Ann Neurol. 1993. PMID: 8338345

5

The effect of zidovudine on skeletal muscle mtDNA in HIV-1 infected patients with mild or no muscle dysfunction.

Casademont J, Barrientos A, Grau JM, Pedrol E, Estivill X, Urbano-Márquez A, Nunes V. Casademont J, et al. Among authors: pedrol e. Brain. 1996 Aug;119 ( Pt 4):1357-64. doi: 10.1093/brain/119.4.1357. Brain. 1996. PMID: 8813297

6

Symptomatic myopathies in HIV-1 infected patients untreated with antiretroviral agents--a clinico-pathological study of 30 consecutive patients.

Masanés F, Pedrol E, Grau JM, Coll-Vinent B, Casademont J, Miró O, Mallolas J, Urbano-Márquez A. Masanés F, et al. Among authors: pedrol e. Clin Neuropathol. 1996 Jul-Aug;15(4):221-5. Clin Neuropathol. 1996. PMID: 8836607

7

Skeletal muscle studies in patients with HIV-related wasting syndrome.

Miró O, Pedrol E, Cebrián M, Masanés F, Casademont J, Mallolas J, Grau JM. Miró O, et al. Among authors: pedrol e. J Neurol Sci. 1997 Sep 10;150(2):153-9. doi: 10.1016/s0022-510x(97)00079-8. J Neurol Sci. 1997. PMID: 9268244

8

Clinical, histological and molecular reversibility of zidovudine myopathy.

Masanés F, Barrientos A, Cebrián M, Pedrol E, Miró O, Casademont J, Grau JM. Masanés F, et al. Among authors: pedrol e. J Neurol Sci. 1998 Aug 14;159(2):226-8. doi: 10.1016/s0022-510x(98)00151-8. J Neurol Sci. 1998. PMID: 9741412

9

Short communication: HIV infection, antiretrovirals, and apoptosis: studies on skeletal muscle.

Miró O, López S, Fernández-Solà J, Garrabou G, Pedrol E, Badia E, Martínez E, Cardellach F, Gatell JM, Casademont J. Miró O, et al. Among authors: pedrol e. AIDS Res Hum Retroviruses. 2005 Aug;21(8):702-5. doi: 10.1089/aid.2005.21.702. AIDS Res Hum Retroviruses. 2005. PMID: 16131309

10

Polyarteritis nodosa confined to calf muscles.

García F, Pedrol E, Casademont J, Mellado B, Córdoba R, Cid M, Grau JM. García F, et al. Among authors: pedrol e. J Rheumatol. 1992 Feb;19(2):303-5. J Rheumatol. 1992. PMID: 1352825 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters